source
- Vitruvias Therapeutics recalls one lot of 30 mg thyroid tablets over super potency riskVitruvias Therapeutics announced a voluntary recall of a single lot (Lot No. 504950) of its 30 mg thyroid tablets to the consumer level. Testing confirmed the tablets could be superpotent, raising…
- FDA issues early alert on Medical Action epidural kits containing recalled sodium chloride ampulesThe FDA’s Center for Devices and Radiological Health has posted an Early Alert warning about certain epidural kits from Medical Action Industries. The alert notes that the kits include sodium chlor…fda medwatch · 3d agoRegulatoryNegative